NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD
10.72
+0.03 (+0.23%)
The current stock price of NRC is 10.72 USD. In the past month the price decreased by -23.7%. In the past year, price decreased by -68.29%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.27 | 90.92B | ||
CVS | CVS HEALTH CORP | 12.05 | 82.46B | ||
DGX | QUEST DIAGNOSTICS INC | 18.91 | 19.39B | ||
LH | LABCORP HOLDINGS INC | 15.67 | 19.10B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.22 | 14.35B | ||
DVA | DAVITA INC | 14.69 | 11.16B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 112.07 | 10.79B | ||
CHE | CHEMED CORP | 23.58 | 8.12B | ||
HIMS | HIMS & HERS HEALTH INC | 52.02 | 6.24B | ||
GH | GUARDANT HEALTH INC | N/A | 5.96B | ||
CRVL | CORVEL CORP | 26.39 | 5.67B | ||
OPCH | OPTION CARE HEALTH INC | 26.97 | 5.40B |
National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. The company is headquartered in Lincoln, Nebraska and currently employs 368 full-time employees. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
NATIONAL RESEARCH CORP
1245 Q Street
Lincoln NEBRASKA 68508 US
CEO: Michael D. Hays
Employees: 435
Company Website: https://nrchealth.com/
Investor Relations: http://nrchealth.com/investor-relations/
Phone: 14024752525
The current stock price of NRC is 10.72 USD. The price increased by 0.23% in the last trading session.
The exchange symbol of NATIONAL RESEARCH CORP is NRC and it is listed on the Nasdaq exchange.
NRC stock is listed on the Nasdaq exchange.
NATIONAL RESEARCH CORP (NRC) has a market capitalization of 244.31M USD. This makes NRC a Micro Cap stock.
NATIONAL RESEARCH CORP (NRC) currently has 435 employees.
NATIONAL RESEARCH CORP (NRC) has a resistance level at 10.73. Check the full technical report for a detailed analysis of NRC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NATIONAL RESEARCH CORP (NRC) has a dividend yield of 4.49%. The yearly dividend amount is currently 0.48. Check the full fundamental report for a detailed analysis of NRC dividend history, reliability and sustainability.
NATIONAL RESEARCH CORP (NRC) will report earnings on 2025-05-06.
The PE ratio for NATIONAL RESEARCH CORP (NRC) is 10.31. This is based on the reported non-GAAP earnings per share of 1.04 and the current share price of 10.72 USD. Check the full fundamental report for a full analysis of the valuation metrics for NRC.
The outstanding short interest for NATIONAL RESEARCH CORP (NRC) is 2.6% of its float. Check the ownership tab for more information on the NRC short interest.
ChartMill assigns a fundamental rating of 5 / 10 to NRC. While NRC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months NRC reported a non-GAAP Earnings per Share(EPS) of 1.04. The EPS decreased by -16.54% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 17.32% | ||
ROA | 18.7% | ||
ROE | 79.21% | ||
Debt/Equity | 1.85 |
ChartMill assigns a Buy % Consensus number of 45% to NRC. The Buy consensus is the average rating of analysts ratings from 8 analysts.